离格
医学
放射治疗
肿瘤科
淋巴结
卵巢癌
内科学
癌症
放射科
作者
Gabriella Macchia,Maura Campitelli,Donato Pezzulla,Simona Lucci,Andrei Fodor,Donatella Russo,Vittoria Balcet,Paolo Bonome,Stefano Durante,Lorena Draghini,Francesca Titone,Giuseppe Roberto D’Agostino,Marinella Tamburo,Martina Ferioli,Edy Ippolito,F. Tortoreto,L. Caravatta,Francesca De Felice,Aida Di Stefano,Mara Fanelli
标识
DOI:10.1016/j.ijrobp.2024.09.036
摘要
MITO-RT3/RAD (NCT04593381) is a prospective multicenter Phase II trial designed to assess the effectiveness and safety of stereotactic body radiotherapy (SBRT) in patients diagnosed with oligometastatic ovarian cancer (oligo-MPR-OC). In this report, we provide the results of the trial in the setting of lymph node disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI